Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Muscle Weakness after Muscle Relaxants: An Audit of Clinical Practice
by
Alkhazrajy, W.
, Khorasanee, A. D.
, Russell, W. J.
in
Age Factors
/ Androstanols - therapeutic use
/ Anesthesia
/ Anesthesia, General
/ Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
/ Biological and medical sciences
/ Cholinesterase Inhibitors - therapeutic use
/ Female
/ Hand Strength
/ Humans
/ Male
/ Medical Audit
/ Medical sciences
/ Muscle Weakness - chemically induced
/ Neostigmine - therapeutic use
/ Neuromuscular Nondepolarizing Agents - therapeutic use
/ Postoperative Period
/ Risk
/ Rocuronium
/ Sex Factors
/ Time Factors
/ Vecuronium Bromide - therapeutic use
2004
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Muscle Weakness after Muscle Relaxants: An Audit of Clinical Practice
by
Alkhazrajy, W.
, Khorasanee, A. D.
, Russell, W. J.
in
Age Factors
/ Androstanols - therapeutic use
/ Anesthesia
/ Anesthesia, General
/ Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
/ Biological and medical sciences
/ Cholinesterase Inhibitors - therapeutic use
/ Female
/ Hand Strength
/ Humans
/ Male
/ Medical Audit
/ Medical sciences
/ Muscle Weakness - chemically induced
/ Neostigmine - therapeutic use
/ Neuromuscular Nondepolarizing Agents - therapeutic use
/ Postoperative Period
/ Risk
/ Rocuronium
/ Sex Factors
/ Time Factors
/ Vecuronium Bromide - therapeutic use
2004
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Muscle Weakness after Muscle Relaxants: An Audit of Clinical Practice
by
Alkhazrajy, W.
, Khorasanee, A. D.
, Russell, W. J.
in
Age Factors
/ Androstanols - therapeutic use
/ Anesthesia
/ Anesthesia, General
/ Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
/ Biological and medical sciences
/ Cholinesterase Inhibitors - therapeutic use
/ Female
/ Hand Strength
/ Humans
/ Male
/ Medical Audit
/ Medical sciences
/ Muscle Weakness - chemically induced
/ Neostigmine - therapeutic use
/ Neuromuscular Nondepolarizing Agents - therapeutic use
/ Postoperative Period
/ Risk
/ Rocuronium
/ Sex Factors
/ Time Factors
/ Vecuronium Bromide - therapeutic use
2004
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Muscle Weakness after Muscle Relaxants: An Audit of Clinical Practice
Journal Article
Muscle Weakness after Muscle Relaxants: An Audit of Clinical Practice
2004
Request Book From Autostore
and Choose the Collection Method
Overview
Residual muscle weakness after general anaesthesia, assessed using handgrip strength, was audited in a teaching hospital. The relationships between residual weakness, the use of muscle relaxants and patient characteristics were examined. Handgrip strength was measured preoperatively, one hour postoperatively and one day postoperatively using a hand dynamometer in 151 patients having general anaesthesia. Forty-nine patients received no muscle relaxant, 34 patients received vecuronium and 68 received rocuronium. Patients were managed by their anaesthetist according to that anaesthetist's clinical choice. All patients who received muscle relaxants received neostigmine. One hour postoperatively, there was a decline in handgrip strength of 16% for the no relaxant group, 24% for vecuronium and 29% for rocuronium. The degree of weakness for the relaxant groups was unrelated to age (P=0.89) but was strongly influenced by the patient's sex. Almost all of the increased weakness with relaxants was found in the female patients. The mean decline in handgrip strength in the male patients who received either vecuronium or rocuronium was similar to that seen when relaxants had not been used (P=0.40). One hour postoperatively, female patients showed a marked decrease in handgrip strength after both vecuronium and rocuronium (32% and 34% respectively, combined P=0.01). These results suggest that in usual clinical practice at our institution, female patients are more likely to have residual weakness after muscle relaxants.
Publisher
Anaesthesia and Intensive Care,Sage Publications Ltd
Subject
/ Androstanols - therapeutic use
/ Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
/ Biological and medical sciences
/ Cholinesterase Inhibitors - therapeutic use
/ Female
/ Humans
/ Male
/ Muscle Weakness - chemically induced
/ Neostigmine - therapeutic use
/ Neuromuscular Nondepolarizing Agents - therapeutic use
/ Risk
This website uses cookies to ensure you get the best experience on our website.